Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Articles

Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue

Nils Halberg, Tayeba Khan, Maria E. Trujillo, Ingrid Wernstedt-Asterholm, Alan D. Attie, Shariq Sherwani, Zhao V. Wang, Shira Landskroner-Eiger, Sean Dineen, Ulysses J. Magalang, Rolf A. Brekken, Philipp E. Scherer
Nils Halberg
1Touchstone Diabetes Center, Department of Internal Medicine
8Department of Biomedical Sciences, Faculty of Health Science, University of Copenhagen, Copenhagen 2100, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tayeba Khan
2Department of Cell Biology, Diabetes Research Center, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York 10461
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria E. Trujillo
2Department of Cell Biology, Diabetes Research Center, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York 10461
3Lead Optimization Pharmacology, Merck Research Laboratories, Rahway, New Jersey 07065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingrid Wernstedt-Asterholm
1Touchstone Diabetes Center, Department of Internal Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan D. Attie
4Department of Biochemistry, University of Wisconsin—Madison, Madison, Wisconsin 53706-1544
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shariq Sherwani
5Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, The Ohio State University, Columbus, Ohio 43210
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhao V. Wang
1Touchstone Diabetes Center, Department of Internal Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shira Landskroner-Eiger
2Department of Cell Biology, Diabetes Research Center, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York 10461
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sean Dineen
6Hamon Center for Therapeutic Oncology and Division of Surgical Oncology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulysses J. Magalang
5Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, The Ohio State University, Columbus, Ohio 43210
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rolf A. Brekken
6Hamon Center for Therapeutic Oncology and Division of Surgical Oncology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp E. Scherer
1Touchstone Diabetes Center, Department of Internal Medicine
7Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Philipp.Scherer@utsouthwestern.edu
DOI: 10.1128/MCB.00192-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Angiogenic capacity of white adipose tissue. (A) The top panels show hypoxia staining using the hypoxia probe pimonidazole in wild-type (WT) and ob/ob EWAT. The two bottom panels show the same hypoxia staining of adipocytes (A) located in close proximity to a mammary tumor (T) and another area of the same fat pad located more distal to the tumor. Bar corresponds to 20 μm. (B) Microarray expression analysis of HIF1α in the EWAT, gastrocnemius (Gastroc), and liver of 4-week-old (4w) and 10-week-old (10w) C57/B6 ob/ob and wild-type mice (five mice/group). A.U, arbitrary units. (C) Amount of HIF1α protein binding to the hypoxia response element in the nuclei from the EWAT of 8-week-old ob/ob and wild-type FVB mice (three mice/group). RFU, relative fluorescence units. (D) Immunohistochemical analysis of HIF1α in the EWAT of 8-week-old FVB wild-type and ob/ob mice. The two left panels show an overview of a fat pad, whereas the two right panels show closeup views of the same fat pads. Arrows denote staining close to lipid droplets but not in the inflamed area in between the adipocytes. The black bar represents 200 μm. The red bar represents 25 μm. (E) Microarray expression analysis of VEGFa in EWAT from 4- and 10-week-old C57/B6 ob/ob and wild-type mice in the EWAT, gastrocnemius, and liver (five mice/group). (F) Functional blood vessels in EWAT of 8-week-old ob/ob FVB and wild-type FVB mice visualized by tail vein injection of biotinylated lectin (Griffonia simplicifolia). Blood vessels are shown in red, and DAPI (4′,6-diamidino-2-phenylindole) staining of the nucleus is shown in blue. Quantification of vascular density was determined as percent Cy3 stain per field normalized to the number of adipocytes (three mice/group). Bar equals 50 μm. Panels B, C, E, and F were analyzed by Student's t test. *, P < 0.05.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Transgenic mouse overexpressing HIF1α in adipose tissue. (A) Quantitative RT-PCR analysis of the aP2 promoter-driven expression of HIF1α-ΔODD shows that the transgene (Tg) expression is very limited in isolated primary macrophages. Within the different fat pads, the transgene expression is heterogeneous, with highest expression in SWAT and lowest in EWAT. (B) Compared to wild-type and ob/ob littermates, the transgene expression results in a significant increase in overall SWAT HIF1α protein binding to the hypoxia response element in HIF1α-ΔODD and HIF1α-ΔODD-ob/ob (two mice/group). RFU, relative fluorescence units. Panels A and B were analyzed by Student's t test. *, P < 0.05.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Metabolic impact of HIF1α-ΔODD in adipose tissue. Hemizygote transgenic mice (sTg) fed either chow (A) or an HFD (B) have elevated body weight compared to those of their littermates (six mice/group for the chow; nine mice/group for the HFD). WT, wild-type mice. (C) Transgene expression in the ob/ob background does not trigger a further increase in body weight (four mice/group). (D) Quantification of adipocyte size in the H&E staining of adipocytes in wild-type and HIF1α transgenic mice (Tg) after 12 weeks of an HFD. Bar = 100 μm. Five mice/group. (E to G) Circulating glucose levels measured during an OGTT in wild-type and hemizygote HIF1α-ΔODD mice (sTg) fed a chow diet (six mice/group) (E) and in mice fed an HFD for 12 weeks (F) and 5 weeks (G) (seven mice/group). (H) Basal- and insulin-stimulated (1.5 U/kg) changes in the ratio of phosphorylated (Ser473) Akt to total levels of Akt in the livers of wild-type and transgenic mice fed an HFD for 12 weeks. Hallmarks of dysfunctional fat are liver triglyceride accumulation (I), increased levels of F4/80 expression in SWAT, measured by quantitative RT-PCR (J), and increased frequency of crown-like structures (K). The increase in crown-like structures can be observed in HIF1α transgenic mice both fed an HFD for 12 weeks or crossed into the ob/ob background. The immunohistochemical analysis (J) shows the macrophage-specific protein MAC-2 in SWAT. Bar = 200 μm. Seven mice/group for the HFD group; six mice/group for mice in the ob/ob background. Panels A, B, C, E, F, and G were analyzed by a two-way ANOVA for repeated measurements; panels D, H, I, J, and K were analyzed by Student's t test. *, P < 0.05; **, P = 0.07.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Fibrosis in dysfunctional white adipose tissue. (A) Masson's trichrome staining of SWAT and EWAT from 8-week-old wild-type mice (WT) and ob/ob FVB mice. Fibrillar collagens, primarily collagen I and III, are stained with blue, as indicated with arrowheads. Nuclei are stained with deep purple, whereas keratin stains red. Bar corresponds to 50 μm; three mice/group. (B) Picrosirius red staining of SWAT and EWAT from 8-week-old wild-type and ob/ob FVB mice. Picrosirius red was visualized under polarized light and shows collagen I in orange and collagen 3 in green. (C) LOX expression in the EWAT, gastrocnemius (Gastroc), and liver for wild-type and 10-week-old (10w) ob/ob C57/B6 mice, measured by the microarray analysis (five mice/group). Panel C was analyzed by Student's t test. *, P < 0.05; 4w, 4 week old; A.U, arbitrary units.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    HIF1α-mediated increased fibrosis in adipose tissue. (A) Col1a1, Col3a1, Col6a1, and elastin expression in SWAT from HIF1α-ΔODD mice and wild types (WT) fed an HFD for 12 weeks, as measured by quantitative RT-PCR (five mice/group). sTg, hemizygote transgenic mice; A.U, arbitrary units. (B) Hydroxyproline content in SWAT and EWAT of HIF1α-ΔODD and wild-type littermates fed an HFD for 12 weeks. Values are normalized to the size of the extracellular matrix space per field (six mice/group). (C) SWAT content of LOX mRNA levels in wild-type, hemizygote, and homozygote transgenic mice (dTg) after 5 weeks of an HFD, as measured by quantitative RT-PCR (five mice/group). (D) Protein levels of both the 50-kDa prepeptide and the 30-kDa active form of LOX in the SWAT of HIF1α-ΔODD and wild-type littermates fed an HFD for 12 weeks, as measured by Western blot analysis. Results were normalized to those of GDI (four mice/group). Tg, transgenic mice. (E) Quantification of the size of the trichrome-laden streaks through the adipose tissue in the SWAT from HIF1α-ΔODD mice versus wild types after 5 weeks of an HFD. Trichrome staining stains collagen fibers in blue, keratin in red, and nuclei in purple. The blue collagen fibers were quantified by measuring the blue area using ImageJ. Bar corresponds to 25 μm. (F) Picrosirius red staining of SWAT from HIF1α-ΔODD mice versus wild types after 5 weeks of an HFD, showing collagen I in orange and collagen III in green. Bar corresponds to 50 μm. (G) Quantification of the trichrome-stained streaks of SWAT of 18-week-old ob/ob and HIF1α-ΔODD-ob/ob mice. Bar corresponds to 25 μm. (H) Picrosirius red staining of SWAT from 18-week-old HIF1α-ΔODD and HIF1α-ΔODD-ob/ob mice. Bar corresponds to 50 μm. Five mice/group for the HFD group and four mice/group for the ob/ob group. Panels A, B, C, D, E, and G were analyzed by Student's t test. *, P < 0.05.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Inhibition of LOX by BAPN treatment leads to an improved metabolic phenotype. (A) Circulating glucose during OGTT of HIF1α-ΔODD mice treated with either vehicle or the LOX inhibitor BAPN for the last 2 weeks of a 5-week HFD experiment (four mice/group). Tg, transgenic mice. (B) Quantification of the collagen-loaded streaks using ImageJ in the SWAT of HIF1α-ΔODD mice treated with either vehicle or the LOX inhibitor BAPN. Bar corresponds to 25 μm (four mice/group). (C) SWAT expression of F4/80 (Emr1) in HIF1α-ΔODD treated with either vehicle or the LOX inhibitor BAPN for the last 2 weeks of a 5-week HFD, as measured by quantitative RT-PCR (four mice/group). A.U, arbitrary units. (D) Schematic illustration of the inverse overlap between the microarray analysis of HIF transgenic versus wild-type mice, with HIF transgenic mice treated with either vehicle or the LOX inhibitor BAPN. Specifically, four important gene clusters are shown, as follows: extracellular matrix, inflammation, blood vessel development, and lymphocyte activation. Shown in the red circle is the number of genes changed by the HIF transgene compared to that of wild-type mice. The black circle, on the other hand, contains the number of genes that were altered by the LOX inhibitor BAPN in the HIF transgenic mice. Underneath each cluster are examples of inversely regulated genes. Panel A is analyzed by the two-way ANOVA for repeated measures; panels B and C are analyzed by Student's t test. *, P < 0.05.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Refined HFD time course. (A) Body weight of wild-type mice fed an HFD for 20 days. (B) Adipocyte area of the SWAT compartment during 20 days of an HFD in wild-type mice. (C to H) mRNA levels of HIF1α, LOX, Col1a1, Col3a1, F4/80, and TNF-α in the SWAT of wild-type mice fed an HFD for 20 days. A.U, arbitrary units. (I) Detection of crown-like structures (indicated by arrowheads) by immunoreactive MAC-2 in SWAT before and during 20 days of an HFD. (A to I) Three mice/time point. CLS, crownlike structure. Data were analyzed by the Student's t test. *, P < 0.05.

  • FIG. 8.
    • Open in new tab
    • Download powerpoint
    FIG. 8.

    Respiratory hypoxia. Expression levels of LOX, Col1a1, Col3a1, GLUT1, F4/80, and VEGFa in the SWAT (A) and muscle (B) in mice breathing ambient air or 10% O2 for 48 h and 10% O2 for 5 days, as measured by quantitative RT-PCR. All data were analyzed by Student's t test, with four mice/group. *, P < 0.05; A.U, arbitrary units.

  • FIG. 9.
    • Open in new tab
    • Download powerpoint
    FIG. 9.

    Schematic representation of the suggested hypothesis. During periods of a positive-energy balance, white adipose tissue expands to meet the need for extra triglyceride storage. As a consequence, adipose tissue becomes hypoxic, thereby activating the transcription factor HIF1α. HIF1α in turn activates a host of genes involved in several physiological responses. Here, we demonstrate that this HIF1α activation initiates a fibrotic response and causes insulin resistance in white adipose tissue. Furthermore, we show that HIF1 induces the collagen cross-linker LOX, which plays a crucial part in this process. Finally, we hypothesize that HIF1-induced fibrosis can be the initiating factor for monocyte infiltration and inflammation.

Tables

  • Figures
  • Additional Files
  • TABLE 1.

    Gene cluster upregulation by HIF1α

    ClusterNo. of genesP value
    Extracellular matrix514.6 × 10−30
    Chemotaxis/inflammation131.5 × 10−15
    Vasculature193.1 × 10−3
    Sarcomere111.2 × 10−2
  • TABLE 2.

    Gene clusters downregulated by HIF1α

    ClusterNo. of genesP value
    T-cell immune response991.9 × 10−32
    T-cell activation284.0 × 10−20
    Humoral response119.4 × 10−5
    Lymph node92.6 × 10−4
  • TABLE 3.

    Overview of differentially expressed genes identified by the microarray cluster analysis

    GeneGene definitionGenBank accession no.EWAT resultsSWAT results
    Fold change in expression levelP value of <0.05?Fold change in expression levelP value of <0.05?
    Col1a1Procollagen, type I, alpha 1 NM_007742.2 1.18No1.65Yes
    Col3a1Procollagen, type III, alpha 1 NM_009930.1 −1.06No1.76Yes
    Col4a1Procollagen, type IV, alpha 1 NM_009931.1 1.07No1.49Yes
    Col5a3Procollagen, type V, alpha 3 NM_016919.1 −1.04No1.55Yes
    Col6a2Procollagen, type VI, alpha 2 NM_146007.1 −1.25No1.84Yes
    Col18a1Procollagen, type XVIII, alpha 1 NM_009929.2 −1.02No1.66Yes
    ElnElastin NM_007925.2 −1.03No1.33Yes
    LumLumican NM_008524 1.06No1.73Yes
    LoxLysyl oxidase NM_010728.1 1.39Yes1.44Yes
    Fn1Fibronectin 1XM_129845.31.15No1.56Yes
    CtgfConnective tissue growth factor NM_010217 0.89No1.38Yes
    Mmp2Matrix metalloproteinase 2 NM_008610.1 1.16No1.58Yes
    S100a4S100 calcium binding protein NM_011311.1 1.10No1.28Yes
    VimVimentin NM_011701.3 1.03No1.41Yes
    Timp1Tissue inhibitor of metalloproteinase 1 NM_011593 2.29No2.44Yes
    Tie1Tyrosine kinase receptor 1 NM_011587.1 −1.05No1.53Yes
    TekEndothelial-specific receptor tyrosine kinase NM_013690.1 −1.09No1.46Yes
    Agpt2Angiopoietin 2 NM_007426.2 1.00No1.85Yes
    HpHaptoglobin NM_017370.1 −1.30No2.10Yes
    Lcn2Lipocalin 2 NM_008491.1 1.63No4.15Yes
    Ccl2C-C motif ligand 2 NM_011333.1 1.12No1.66Yes
    Ccl3C-C motif ligand 3 NM_011337.1 1.96No1.71Yes
    Tlr13Toll-like receptor 13 NM_205820.1 1.18No2.05Yes
    Cd68CD68 antigen NM_009853.1 1.06No2.41Yes
    Emr1Epidermal growth factor-like module containing mucin-like, hormone receptor-like sequence 1 NM_010130.1 1.01No1.53Yes
    Atp6v0a1ATPase, H+ transporting, lysosomal V0 subunit isoform 1 NM_016920.1 −1.29No1.71Yes
    Atp6ap2ATPase, H+ transporting, lysosomal accessory protein 2 NM_027439 −1.05No1.55Yes
    Cd4CD4 antigen NM_013488.1 1.01No−1.71Yes
    Cd3eCD3 antigen, epsilon polypeptide NM_007648 −1.04No−26.07Yes
    Cd3gCD3 antigen, gamma polypeptide NM_009850.1 1.08No−21.97Yes
    Cd2CD2 antigen NM_013486.1 1.00No−5.90Yes
    Cd5CD5 antigen NM_007650.2 1.04No−8.87Yes
    Xcl1Chemokine (C motif) ligand 1 NM_008510.1 −1.04No−2.45Yes
    Ccl5Chemokine (C-C motif) ligand 5 NM_013653.1 −1.02No−11.76Yes
    Ccl21aChemokine (C-C motif) ligand 21a (leucine) NM_011335.1 −2.09No−9.61Yes
    Ccl21cChemokine (C-C motif) ligand 21c (leucine) NM_023052 −1.85No−9.64Yes
    Ccl21bChemokine (C-C motif) ligand 21b (serine) NM_011124.3 −2.20No−9.98Yes

Additional Files

  • Figures
  • Tables
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 - Legends to Fig. S1 to S22
      Zipped Word file, 10K.
    • Supplemental file 2 - Fig. S1 (HIF1α immunohistochemical analysis), S2 and S12 to S15 (Microarray expression analyses), S3 (RT-PCR analysis of HIF1α transgene and actin tissue distribution), S4 (Leptin production in SWAT), S5 (Body weights of mice during 5 weeks of HFD), S6 and S7 (Circulating [S6] and plasma [S7] glucose levels), S8 to S10 (Quantitative RT-PCR measurements), S11 (SWAT lactate content), S16 and S17 (LOX expression [S16] and induction [S17] in SWAT and EWAT), S18 (Adiponectin, Lox, and HIF1α expression), S19 and S20 (mRNA levels), and S21 and S22 (Expression levels of different proteins)
      Zipped PDF file, 2.6MB.
    • Supplemental file 3 - Table S1 (Blood chemistry analysis in different mice after fasting)
      Zipped Word file, 8K.
PreviousNext
Back to top
Download PDF
Citation Tools
Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue
Nils Halberg, Tayeba Khan, Maria E. Trujillo, Ingrid Wernstedt-Asterholm, Alan D. Attie, Shariq Sherwani, Zhao V. Wang, Shira Landskroner-Eiger, Sean Dineen, Ulysses J. Magalang, Rolf A. Brekken, Philipp E. Scherer
Molecular and Cellular Biology Jul 2009, 29 (16) 4467-4483; DOI: 10.1128/MCB.00192-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue
Nils Halberg, Tayeba Khan, Maria E. Trujillo, Ingrid Wernstedt-Asterholm, Alan D. Attie, Shariq Sherwani, Zhao V. Wang, Shira Landskroner-Eiger, Sean Dineen, Ulysses J. Magalang, Rolf A. Brekken, Philipp E. Scherer
Molecular and Cellular Biology Jul 2009, 29 (16) 4467-4483; DOI: 10.1128/MCB.00192-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Adipose Tissue, White
fibrosis
Hypoxia-Inducible Factor 1, alpha Subunit
insulin resistance

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549